A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2004
10/06/2004	EP1463805A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
10/06/2004	EP1463804A1 Improved gamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux
10/06/2004	EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
10/06/2004	EP1463757A2 Antisense compounds directed against human csf-1
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463748A2 Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
10/06/2004	EP1463743A1 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
10/06/2004	EP1463735A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/06/2004	EP1463733A2 Mitotic kinesin inhibitors
10/06/2004	EP1463731A1 Dibenzodiazepine derivates, their preparation and use
10/06/2004	EP1463730A1 Pyrazoloparidazine derivatives
10/06/2004	EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function
10/06/2004	EP1463727A2 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
10/06/2004	EP1463726A2 Aromatic thioether liver x-receptor modulators
10/06/2004	EP1463725A1 Process and intermediates for pyridazinone antidiabetic agents
10/06/2004	EP1463723A1 Process for the preparation of simvastatin
10/06/2004	EP1463722A2 PREPARATION OF CIS-FUSED 3,3a,8,12b-TETRAHYDRO-2-H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES
10/06/2004	EP1463721A1 Compounds for imaging alzheimer's disease
10/06/2004	EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof
10/06/2004	EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004	EP1463715A1 Novel glucagon antagonists
10/06/2004	EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004	EP1463713A1 Prodrugs of excitatory amino acids
10/06/2004	EP1463711A1 A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
10/06/2004	EP1463707A2 A group of novel anti-cancer compounds with specific structure
10/06/2004	EP1463704A1 Antibacterial compounds
10/06/2004	EP1463563A1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
10/06/2004	EP1463558A2 Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
10/06/2004	EP1463553A1 Medicament dispenser
10/06/2004	EP1463545A1 Intraluminal device with a coating containing a therapeutic agent
10/06/2004	EP1463541A2 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours
10/06/2004	EP1463539A1 Controlled release therapeutic wound dressings
10/06/2004	EP1463531A1 Methods for inhibiting ocular processes
10/06/2004	EP1463529A2 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy
10/06/2004	EP1463528A1 Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatique syndrome and pain
10/06/2004	EP1463518A2 Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression
10/06/2004	EP1463517A2 Analyse permettant de detecter des facteurs qui modulent l'expression d'ingap
10/06/2004	EP1463515A2 Isoflavone composition for oral delivery
10/06/2004	EP1463514A2 Utilization of rutins and aescins in the treatment of ocular circulatory disturbances
10/06/2004	EP1463513A1 Stabilized brivudine topical formulations
10/06/2004	EP1463511A1 Combination cancer therapy
10/06/2004	EP1463510A2 Administration of vasopeptidase inhibitors to reduce pulse pressure
10/06/2004	EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof
10/06/2004	EP1463508A1 Selective dopamine d3 receptor agonists for the treatment of sexual dysfunction
10/06/2004	EP1463507A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors
10/06/2004	EP1463506A1 Substituted quinazoline derivatives as inhibitors of aurora kinases
10/06/2004	EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
10/06/2004	EP1463504A1 Compositions comprising epothilones and their use for the treatment of the carcinoid syndrome
10/06/2004	EP1463503A1 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes
10/06/2004	EP1463502A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
10/06/2004	EP1463501A1 Cis-imidazolines as mdm2 inhibitors
10/06/2004	EP1463500A1 Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
10/06/2004	EP1463499A1 Method for treating circadian rhythm disruptions
10/06/2004	EP1463498A1 Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
10/06/2004	EP1463497A2 Treating muscle wasting with selective androgen receptor modulators
10/06/2004	EP1463496A2 Method for treating bronchial constriction and bronchospam
10/06/2004	EP1463495A2 Agents and methods for treatment of cancer
10/06/2004	EP1463494A1 Use of polycyclic phenolic compounds for the treatment of opthalmic diseases
10/06/2004	EP1463493A1 Methods of inducing ovulation-using a non-polypeptide camp level modulator
10/06/2004	EP1463491A1 Thin film with non-self-aggregating uniform heterogeneity, process for ther production and drug delivery systems made therefrom
10/06/2004	EP1463489A1 Composite dosage forms
10/06/2004	EP1463487A1 Liposomal delivery of vitamin e based compounds
10/06/2004	EP1463486A2 Anaesthetic compositions and method for their administration
10/06/2004	EP1463483A1 New composition
10/06/2004	EP1463481A2 Methods and compositions for treatment of central nervous system disorders
10/06/2004	EP1463440A2 Prevention of flap necrosis in plastic surgery
10/06/2004	EP1463438A2 Endomural therapy
10/06/2004	EP1463412A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
10/06/2004	EP1383481B1 Process for manufacture of biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/06/2004	EP1335727B1 Method for inhibiting cataracts
10/06/2004	EP1326832B1 Chemical compounds
10/06/2004	EP1318837B1 Method of treating estrogen receptor positive carcinoma
10/06/2004	EP1303632B1 Galactomannan oligosaccharides and methods for the production and use thereof
10/06/2004	EP1303276B1 A bioavailable dosage form of loratadine
10/06/2004	EP1303251B1 Composition, in particular cosmetic, containing dhea and/or a chemical or biological precursor or derivative thereof, and a metalloproteinase inhibitor
10/06/2004	EP1296981B1 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/06/2004	EP1291349B1 Malto-oligosaccharide derivatives and use thereof
10/06/2004	EP1282395B1 Use of ellagic acid as anti-pollution cosmetic agent
10/06/2004	EP1263300B1 Improvements in or relating to solubilisation of flavonols
10/06/2004	EP1255548A4 Use of thiostrepton as an anti-mycobacterial agent
10/06/2004	EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
10/06/2004	EP1244426A4 Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer
10/06/2004	EP1232141B1 Ethers of o-desmethyl venlafaxine
10/06/2004	EP1210325B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
10/06/2004	EP1206484B1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/06/2004	EP1185521B1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors
10/06/2004	EP1185256B1 Utilization of a highly fluorinated oligomeric alkan in ophthalmology
10/06/2004	EP1181934B1 1,4-dihydropyridine derivatives as inhibitors for optic hypofunction caused by optic nerve cell injury induced by factors other than optic circulatory disorder
10/06/2004	EP1169312B1 Glucokinase activators
10/06/2004	EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004	EP1161225B1 Metered dose inhalers with isobutane as propellant
10/06/2004	EP1154993B1 Thioamide derivatives
10/06/2004	EP1144414B1 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/06/2004	EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors
10/06/2004	EP1140080B1 Use of riluzole for treating acoustic traumas
10/06/2004	EP1135379B1 Antitumor dibenzofluorene derivatives
10/06/2004	EP1135163B1 Topical compositions comprising ascomycins
10/06/2004	EP1133284B1 A process for the preparation of crystalline particles
10/06/2004	EP1133283B1 A method of producing drug particles
10/06/2004	EP1101112B1 Leptin-mediated gene-induction

1 ... 4935 4936 4937 4938 4939 4940 4941 4942 4943 4944 4945 4946 4947 4948 4949 4950 4951 4952 4953 4954 4955 ... 7860